MobiHealthNews, "digital health's publication of record covering breaking news and contextualizing the trends for healthcare innovators,” recently cited Civica Rx as one of the few companies working to manufacture or distribute lower-cost drugs.
FierceHealthcare names Civica Rx as one of its 2019 “Fierce 15” companies, designating it as one of the most promising healthcare companies in the industry.
In reflecting on 2018, The Conversation, via the San Francisco Chronicle picks Civica Rx as one of its top three “solutions that chip away at big problems.”
Civica Rx comes in as #4 and #5 in Becker’s Hospital Review’s “top 10 supply chain stories of 2018.”
A Life Science Leader guest columnist provides a summary analysis of Civica Rx in his feature, “Assessing the impact of the Civica business model for pharma manufacturers.”